Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma. Issue 38 (18th September 2020)
- Record Type:
- Journal Article
- Title:
- Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma. Issue 38 (18th September 2020)
- Main Title:
- Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma
- Authors:
- Wang, Lingxiang
Yang, Zhulin
Wu, Zhengchun
He, Jun
Xu, Shu
Li, Daiqiang
Zou, Qiong
Yuan, Yuan - Other Names:
- Ding. Jianxun section editor.
- Abstract:
- Abstract : Abstract: The expression of Cystathionine beta-synthase (CBS) and Chemokine ligand 21 (CCL21) is associated with the tumorigenesis and progression of a variety of tumors, but whether alterations in their expression levels correlates with the carcinogenesis and progression of EHCC is still unknown. This study investigated the clinicopathological significance of CBS and CCL21 expression in EHCC. We investigated the correlations between the expression of CBS and CCL21 and clinicopathological characteristics in EHCC using EnVision immunohistochemistry. The expression of CBS and CCL21 was significantly higher in EHCC tumors than in nontumor tissues ( P < .05 and P < .01). EHCC patients with CBS and CCL21 expression combined with lymph node metastasis, tumor cell invasion, and TNM III/IV stage had more severe conditions than those with no lymph node metastasis, distant invasion and TNM I/II stage ( P < .01). Kaplan-Meier survival analysis showed that the overall survival rates for EHCC patients with negative CBS or CCL21 reaction were significantly higher than those for patients with positive CBS or CCL21 reaction(( P < .01). CBS or CCL21 expression was revealed as an independent poor prognostic factor for EHCC patients by Cox multivariate analysis. The present study indicates that CBS and CCL21 expression is closely associated with the pathogenesis of clinical, pathological and biological behaviors and poor prognosis in EHCC.
- Is Part Of:
- Medicine. Volume 99:Issue 38(2020)
- Journal:
- Medicine
- Issue:
- Volume 99:Issue 38(2020)
- Issue Display:
- Volume 99, Issue 38 (2020)
- Year:
- 2020
- Volume:
- 99
- Issue:
- 38
- Issue Sort Value:
- 2020-0099-0038-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-09-18
- Subjects:
- cystathionine beta-synthase -- chemokine ligand 21 -- extrahepatic cholangiocarcinoma -- immunohistochemistry -- prognosis
Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000022255 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14542.xml